Boston Scientific Corp. (NYSE: BSX) Q2 2021 earnings call dated Jul. 27, 2021 Corporate Participants: Lauren Tengler -- Investor Relations Michael F. Mahoney -- Chairman and
Boston Scientific Corp.
-(BSX)
Get the latest Boston Scientific Corp. (BSX) stock news, earnings analysis, earnings conference calls, earnings transcripts from AlphaStreet.
Earnings calendar for the week of July 26
After showing weakness at the beginning of the week, benchmark stock indexes made steady gains even as economic recovery gathered steam. On
Boston Scientific Corp. (BSX) Q1 2021 Earnings Call Transcript
Boston Scientific Corp. (NYSE: BSX) Q1 2021 earnings call dated Apr. 28, 2021 Corporate Participants: Susie Lisa -- Vice President, Investor Relations Michael F.
The worst seems to be over for Boston Scientific. Is the stock a buy?
The pandemic has had a mixed impact on the healthcare sector since its outbreak more than a year ago, putting the emergency
Boston Scientific Corp. (BSX) Q4 2020 Earnings Call
Boston Scientific Corp. (NYSE: BSX) Q4 2020 earnings call dated Feb. 03, 2021 Corporate Participants: Susie Lisa — Vice President, Investor Relations Michael F. Mahoney — Chairman
Boston Scientific Corp. (BSX) Q4 2020 Earnings Call Transcript
Boston Scientific Corp. (NYSE: BSX) Q4 2020 earnings call dated Feb. 03, 2021 Corporate Participants: Susie Lisa -- Vice President, Investor Relations Michael F.
Earnings calendar for the week of February 1
In a week that saw one of the worst stock selloffs, Gamestop came under spotlight after the stock experienced unprecedented fluctuations, marked
Infographic: Boston Scientific Corporation (BSX) Q1 2020 earnings results
Boston Scientific Corporation (NYSE: BSX) announced first quarter 2020 earnings results today. Sales grew 2% to $2.54 billion compared to the same
Stock Analysis: COVID-19 testing kit gives Abbott (ABT) an edge over Boston Scientific (BSX)
When Wall Street suffered huge losses after business activity was disrupted across the country due to the COVID-19 outbreak, one industry that
Boston Scientific Corp (NYSE: BSX) Q4 2019 Earnings Call Transcript
Boston Scientific Corp (NYSE: BSX) Q4 2019 Earnings Conference Call February 05, 2020 Corporate Participants: Susie Lisa -- Vice President of Investor Relations Michael
Boston Scientific Corporation (BSX): Q4 2019 Earnings Snapshot
-- Boston Scientific (NYSE: BSX) reported earnings of $0.46 per share in the fourth quarter of 2019, vs. $0.44 per share expected. -- Total
Boston Scientific (BSX) stock drops on weak Q4 preliminary revenue
Boston Scientific Corporation (NYSE: BSX) stock dropped over 6% on Tuesday after its preliminary fourth-quarter report. The shares have fallen over 5%
Boston Scientific (BSX) Q3 earnings beat on 13% sales growth; stock gains
Earnings of medical device maker Boston Scientific Corporation (NYSE: BSX) increased and topped expectations in the third quarter, aided by a 13%
Boston Scientific Q2 profit dips 72% but beats estimates
Boston Scientific Corporation (NYSE: BSX) reported a 72% dip in earnings for the second quarter due to higher costs and expenses as well
Boston Scientific stock falls as Q1 earnings and sales missed consensus estimates
Boston Scientific (NYSE: BSX) reported first quarter 2019 earnings results before the market opened today. The medical technology company's earnings and sales
Boston Scientific Q4 earnings beat on strong sales growth; stock moves up
Broad-based sales growth, marked by a double-digit increase in emerging markets, lifted Boston Scientific’s (BSX) fourth-quarter earnings, which surpassed the Wall Street
Earnings preview: Cardiovascular to drive Boston Scientific Q4 results
Boston Scientific Corporation (BSX) is set to report its fourth-quarter earnings results on Wednesday before the bell. The medical device manufacturer's results
Cypress Semiconductor soars after beating Q4 earnings and revenue projections
Cypress Semiconductor Corp. (CY) Q4 earnings and revenue surpassed analysts' estimates. The company reported EPS of $0.35 on revenue of $604.5 million.
Abbott earnings preview: Pharma, medical devices to drive Q4 results
Healthcare giant Abbott Laboratories (ABT) is expected to post upbeat results for the fourth quarter on Wednesday before the bell, despite the